bioMérieux SA has 15,084 employees, according to Revelio Labs workforce intelligence data. The YoY growth rate is 3.5%.
Data source: Revelio Labs Coverage: Global workforce Latest update: September 2025
Pioneering Diagnostics A world leader in the field of in vitro diagnostics for 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock market. Symbol: BIM – ISIN Code: FR0013280286 Reuters: BIOX.PA/Bloomberg: BIM.FP
As of September 2025
bioMerieux
workforce metrics
Headcount
15.1k
Avg. Salary
$75k
Tenure
5.3yr
Growth Rate
3.5%
Hiring Rate
Attrition Rate
For even more metrics data,
reach out to our sales team.
Interactive chart of bioMerieux annual worldwide employee count from 2023 to 2025.
Would you like to see the latest employee headcount data?
Would you like to see the latest employee geographic data?
Interactive chart of bioMerieux annual active job postings from 2023 to 2025.
Would you like to see the latest active job postings data?
Sentiment Topics
Would you like to see the latest employee sentiment data?